Role of sublingual asenapine in treatment of schizophrenia
Leslie CitromeNew York University School of Medicine, Department of Psychiatry, New York, NY, USAAbstract: Asenapine tablets are a new option for the treatment of schizophrenia. Sublingual administration is essential because bioavailability if ingested is less than 2%. Efficacy is supported by acute...
Enregistré dans:
Auteur principal: | Citrome L |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/589f49acb84f4d5fa42f9e3e44a0e5f2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
par: Warren CG, et autres
Publié: (2013) -
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
par: Delia Bishara, et autres
Publié: (2009) -
The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
par: Pompili M, et autres
Publié: (2011) -
Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
par: Gao K, et autres
Publié: (2013) -
Role of aripiprazole in treatment-resistant schizophrenia
par: Mossaheb N, et autres
Publié: (2012)